Pre- and post-initiation modulating effects of green tea ingestion on rat hepatocarcinogenesis

  • Kim, Hyung-Sook (Pulmuone Holdings Co. Ltd.) ;
  • Kim, Hee-Seon (Department of Food Science and Nutrition, Soonchunhyang University) ;
  • Choi, Hay-Mie (Department of Food Science and Nutrition, Seoul National University)
  • Published : 2008.12.31


The purpose of this study was to investigate the effects of green tea ingestion on hepatocarcinogenesis before and after its initiation. Male Sprague-Dawley rats were fed an AIN76A diet with or without green tea. Initiation was induced by a single dose (200 mg/kg) of diethylnitrosamine at week 4 and 0.02% (w/w) 2-acetylaminofluorene was supplied in the diets. The control group had free access to water for 13 weeks (CTR13). Tea infusion was provided from the beginning of the experiment for 13 weeks (PRE13) or from the post-initiation stage until week 13 (POST13). Three other groups (CTR24, PRE24 and POST24) were added to examine the longer-term effects (24 weeks) with the same experimental design. The percentage area of liver sections that were positive for hepatic placental glutathione S-transferase (GST-P), which was used as a marker of preneoplastic lesions, was smaller in PRE13 ($20.2{\pm}5.0%$, $mean{\pm}SD$) and POST13 ($26.0{\pm}4.8%$) than in CTR13 ($33.2{\pm}5.8%$, p<0.05). Over the longer period, the GST-P lesions were significantly smaller for both PRE24 and POST24 ($21.6{\pm}8.5%$ and $22.2{\pm}4.0%$, respectively) than for CTR24 ($28.6{\pm}5.1%$, p<0.05), but there was no significant difference between PRE24 and POST24. The liver content of thiobarbituric acid reactive substances was significantly lower in the tea groups than in the controls (p<0.05). However, no significant differences were observed among groups of GST activity. The results show that tea consumption exhibits a stronger short-term initiation-inhibiting ability in liver carcinogenesis, but over a longer period, the preventive effects of green tea ingestion do not differ in post- and pre-initiation.



  1. Alagol H, Erdem E, Sancak B, Turkmen G, Camlibel M & Bugdayci G (1999). Nitric oxide biosynthesis and malondiadehyde levels in advanced breast cancer. Aust N Z J Surg 69:647-650
  2. Ahmad N, Katiyar SK & Mukhtar H (2001). Antioxidants in chemoprevention of skin cancer. Curr Probl Dermatol 29:128-139
  3. American Institute of Nutrition (1980). Second report on the AIN Ad Hoc Committee on standards for nutritional studies. J Nutr 110:1726
  4. Arab L & Il'yasova D (2003). The epidemiology of tea consumption and colorectal cancer incidence. J Nutr 133:3310S-3318S
  5. Barret JR (2002). Plants provide prevention. Environ Health Perspect 110:180
  6. Buege JA & Aust SD (1978). Microsomal lipid peroxidation. Methods Enzymol 52:302-310
  7. Chen C, Yu R, Owuor ED & Kong AN (2000). Activation of antioxidant-response element (ARE), miotogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 23:605-612
  8. Conney AH, Lou YR, Xie JG, Osawa T, Newmark HL, Liu Y, Chang RL & Huang MT (1997). Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc Soc Exp Biol Med 216:234-245
  9. Dreosti IE (1996). Bioactive ingredients: antioxidants and polyphenols in tea. Nutr Rev 54:S51-58
  10. Farombi EO, Tahnteng JG, Agboola AO, Nwankwo JO & Emerole GO (2000). Chemoprevention of 2-acetylaminofluorene-induced hepatotoxicity and lipid peroxidation in rats by Kolaviron-A Garcinia kola Seed Extract. Food Chem Toxicol 38:535-541
  11. Feng Q, Kumagai T, Torii Y, Nakamura Y, Osawa T & Uchida K (2001). Anticarcinogenic antioxidants as inhibitors against intracellular oxidative stress. Free Radic Res 35:779-788
  12. Gescher AJ, Sharma RA & Steward WP (2001). Cancer chemoprevention by dietary constituents: a tale of failure and promise. Lancet Oncol 2:371-379
  13. Guyton KZ & Kensler TW (1997). Prevention of liver cancer. Curr Opin Oncol 9:492-496
  14. Habig WH, Pabst MJ & Jakoby WB (1974). Glutathione S-transferase. J Biol Chem 249:7130-7139
  15. Henning SM, Niu Y & Liu Y (2005). Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J Nutr Biochem 16:610-616
  16. Huang H & Xu X (2004). Anticancer activity of tea: evidence from recent animal experiments and human studies. Journal of Tea Science 24:1-11
  17. Ke L, Yu P, Zhang ZX, Huang SS, Huang G & Ma XH (2002). Congou tea drinking and oesophageal cancer in South China. Br J Cancer 86:346-347
  18. Korea National Statistical Office (2008). 2007 Annual report on the cause of death statistics, Korea National Statistical Office, Seoul. Republic of Korea
  19. Lambert JD & Yang CS (2003). Mechanisms of cancer prevention by tea constituents. J Nutr 133:3262S-3267S
  20. Lin JK (2002). Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Arch Pharm Res 25:561-571
  21. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951). Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
  22. McKay DL & Blumberg JB (2002). The role of tea in human health: An update. J Am Coll Nutr 21:1-13
  23. Miyata M, Takano H, Guo LQ, Nagata K & Yamazoe Y (2004). Grapefruit juice intake does not enhance but rather protects against aflatoxin B1-induced liver DNA damage through a reduction in hepatic CYP3A activity. Carcinogenesis 25:203-209
  24. Omura T & Sato R (1964). The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 239:2370-2378
  25. Ozdemirler G, Aykac G, Uysal M & Oz, H (1999). Liver lipid peroxidation and glutathione-related defence enzyme systems in mice treated with paracetamol. J Appl Toxicol 14:297-299
  26. Sohn OS, Surace A, Fiala ES, Richie JP, Colosimo S, Zang E & Weisburger JH (1994). Effect of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat. Xenobiotica 24:119-127
  27. Su LJ & Arab L (2002). Tea consumption and the reduced risk of colon cancer-results from a national prospective cohor study. Public Health Nutr 5:419-426
  28. Takada M, Ku Y & Habara K (2002). Inhibitory effect of epigallocatechin- 3-gallate on growth and invasion in human biliary tract carcinoma cells. World J Surg 26:683-686
  29. Tatematsu M, Mera Y, Inoue T, Satoh K, Sato K & Ito N (1988). Stable phenotypic expression of glutathione S-transferase placental type and unstable phenotypic experssion of ${\gamma}-glutamyltransferase$ in rat liver preneoplastic and neoplastic lesion. Carcinogenesis 9:215-220
  30. Tian Q, Miller EG, Ahmad H, Tang L & Patil BS (2001). Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr Cancer 40:180-184
  31. Yang CS, Landau JM, Huang MT & Newmark HL (2001). Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21:381-406
  32. Yang CS, Maliakal P & Meng X (2002). Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42:25-54
  33. Yang G-Y, Liao J, Kim K, Yurkow EH & Yang CS (1998). Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19:611-616